Mesenteriale Ischämie – Outcome nach operativer Therapie
FC Popp, Pompiliu Piso(Krankenhaus Barmherzige Brüder), Philipp Renner(Robert Bosch Hospital), Stefan Feuerbach(University of Regensburg), MH Dahlke(University Hospital Regensburg), SA Lang(University Hospital Regensburg), Przemyslaw Slowik(University of Regensburg), Oliver Stoeltzing(The University of Texas MD Anderson Cancer Center), HJ Schlitt, L. Asshoff
Cited by 0
Related Papers
Immunomodulatory Effects of Mesenchymal Stem Cells in a Rat Organ Transplant Model
|Transplantation|2006|255
Mesenchymal stem cells can induce long-term acceptance of solid organ allografts in synergy with low-dose mycophenolate
|Transplant Immunology|2008|198
Regulation of Hypoxia-Inducible Factor-1α, Vascular Endothelial Growth Factor, and Angiogenesis by an Insulin-Like Growth Factor-I Receptor Autocrine Loop in Human Pancreatic Cancer
|American Journal Of Pathology|2003|175
Peritoneal carcinomatosis: patients selection, perioperative complications and quality of life related to cytoreductive surgery and hyperthermic intraperitoneal chemotherapy
|World Journal of Surgical Oncology|2009|169